About PURMX Therapeutics,Inc.
Creation of optimal nucleic acid medicine for disease treatment with proprietary technology PURMX's solution is a drug discovery seed of small RNA nucleic acid drugs that fine-tune many target genes and deliver unprecedented therapeutic effects. PURMX already possesses a large amount of functional RNA screening data, which is being further expanded. The first stage of innovative nucleic acid medicine seeds is MIRX002. MIRX002 is a nucleic acid medicine for malignant pleural mesothelioma. We have completed non-clinical trials and are conducting investigator-initiated clinical trials at Hiroshima University Hospital starting in 2021.
- Employees
- 11 to 50
- Headquarters
- Japan
Leadership
The top of PURMX Therapeutics,Inc.'s org chart, with how many people report into each leader.
Takeshi Ishiga
Chief Financial Officer
Jobs at PURMX Therapeutics,Inc.
No open positions right now. Explore more companies on TheJobsMap.